ABSTRACT
Patients of chronic obstructive pulmonary disease (COPD) during COVID-19 pandemic have higher morbidity. Treatment of these patients require aerosolization procedures like nebulization and noninvasive modalities for ventilation like non-invasive ventilation (NIV) and high flow nasal cannula (HFNC). Role of these procedures in corona virus transmission when treating a case of acute exacerbation of chronic obstructive pulmonary disease should be further studied.
Subject(s)
Betacoronavirus , Coronavirus Infections/prevention & control , Hospitalization , Infection Control/organization & administration , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Pulmonary Disease, Chronic Obstructive/complications , Pulmonary Disease, Chronic Obstructive/therapy , COVID-19 , Cannula , Coronavirus Infections/epidemiology , Coronavirus Infections/transmission , Disease Progression , Humans , Noninvasive Ventilation , Pneumonia, Viral/epidemiology , Pneumonia, Viral/transmission , SARS-CoV-2ABSTRACT
Iidiopathic pulmonary fibrosis (IPF) diagnosis and treatment during this COVID-19 pandemic have been affected. COVID-19 has not only impacted the prognosis of these patients but also the approach to these patients. Pulmonary function tests (PFT) and lung biopsies are less encouraged now. Traditional antifibrotics used in IPF should be encouraged irrespective of patient lung function and in those with non-definite usual interstitial pneumonia in high resolution computed tomography.
Subject(s)
COVID-19/diagnosis , Idiopathic Pulmonary Fibrosis/diagnosis , Idiopathic Pulmonary Fibrosis/therapy , COVID-19/complications , Humans , Idiopathic Pulmonary Fibrosis/etiology , Idiopathic Pulmonary Fibrosis/physiopathology , Lung/pathology , Respiratory Function Tests , Respiratory Insufficiency/etiology , Severity of Illness IndexABSTRACT
e two diseases together.